Cheng Man, Lu Dan, Li Kexin, Wang Yan, Tong Xiwen, Qi Xiaolong, Yan Chuanzhu, Ji Kunqian, Wang Junlin, Wang Wei, Lv Huijiao, Zhang Xu, Kong Weining, Zhang Jian, Ma Jiaxin, Li Keru, Wang Yaheng, Feng Jingyu, Wei Panpan, Li Qiushuang, Shen Chengyong, Fu Xiang-Dong, Ma Yuanwu, Zhang Xiaorong
State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
State Key Laboratory of Respiratory Health and Multimorbidity, National Center of Technology Innovation for Animal Model and National Human Diseases Animal Model Resource Center, NHC Key Laboratory of Comparative Medicine, Key Laboratory of Pathogen Infection Prevention and Control (Ministry of Education), Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Nat Neurosci. 2025 Apr;28(4):748-756. doi: 10.1038/s41593-025-01896-4. Epub 2025 Mar 11.
Amyotrophic lateral sclerosis (ALS) is categorized into ~10% familial and ~90% sporadic cases. While familial ALS is caused by mutations in many genes of diverse functions, the underlying pathogenic mechanisms of ALS, especially in sporadic ALS (sALS), are largely unknown. Notably, about half of the cases with sALS showed defects in mitochondrial respiratory complex IV (CIV). To determine the causal role of this defect in ALS, we used transcription activator-like effector-based mitochondrial genome editing to introduce mutations in CIV subunits in rat neurons. Our results demonstrate that neuronal CIV deficiency is sufficient to cause a number of ALS-like phenotypes, including cytosolic TAR DNA-binding protein 43 redistribution, selective motor neuron loss and paralysis. These results highlight CIV deficiency as a potential cause of sALS and shed light on the specific vulnerability of motor neurons, marking an important advance in understanding and therapeutic development of sALS.
肌萎缩侧索硬化症(ALS)分为约10%的家族性病例和约90%的散发性病例。虽然家族性ALS是由许多功能各异的基因突变引起的,但ALS的潜在致病机制,尤其是散发性ALS(sALS)的致病机制,在很大程度上尚不清楚。值得注意的是,约一半的sALS病例表现出线粒体呼吸复合物IV(CIV)缺陷。为了确定这种缺陷在ALS中的因果作用,我们使用基于转录激活样效应物的线粒体基因组编辑技术在大鼠神经元的CIV亚基中引入突变。我们的结果表明,神经元CIV缺陷足以导致许多ALS样表型,包括胞质TAR DNA结合蛋白43重新分布、选择性运动神经元丧失和瘫痪。这些结果突出了CIV缺陷作为sALS的潜在原因,并揭示了运动神经元的特定易损性,标志着在sALS的理解和治疗开发方面取得了重要进展。